WELCOME
Revotar develops innovative anti-inflammatory drugs for inflammatory indications such as chronic obstructive pulmonary disease (COPD), asthma, acute lung injury or (ALI), ischemia / reperfusion, and psoriasis.
Revotar develops innovative anti-inflammatory drugs for inflammatory indications such as chronic obstructive pulmonary disease (COPD), asthma, acute lung injury or (ALI), ischemia / reperfusion, and psoriasis.